Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674896 | SCV000800306 | uncertain significance | Pendred syndrome | 2018-06-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764680 | SCV000895811 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 4; Pendred syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001785701 | SCV002027021 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 4 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000674896 | SCV002027022 | uncertain significance | Pendred syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002532167 | SCV003440151 | uncertain significance | not provided | 2022-05-09 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 670 of the SLC26A4 protein (p.Val670Ala). This variant is present in population databases (rs200712253, gnomAD 0.1%). This missense change has been observed in individual(s) with clinical features of Pendred syndrome (PMID: 25372295). ClinVar contains an entry for this variant (Variation ID: 558599). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC26A4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |